Clinical trial
Combination Chemotherapy With or Without Cetuximab in Treating Patients With…
NCT00265811 · Federation Francophone de Cancerologie Digestive, Other · Completed
Key facts
| NCT number | NCT00265811 |
|---|---|
| Title | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery |
| Official title | Adjuvant Treatment of Fully Resected Stage III Colon Cancer With FOLFOX-4 Versus FOLFOX-4 Plus Cetuximab |
| Lead sponsor | Federation Francophone de Cancerologie Digestive, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Folfox, Cetuximab |
| Enrollment | 2,559 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Jun 22, 2010 |
| First posted | Dec 15, 2005 |
| Last update posted | Nov 9, 2020 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: